Abstract：
UNASSIGNED: Ectopic pregnancy is a major contributor to maternal morbidity and mortality across the globe.
UNASSIGNED: This study aims to investigate the clinical benefits of laparoscopic surgery in treating ectopic pregnancy, and its impact on tubal patency and reproductive outcomes.
UNASSIGNED: A clinical study was conducted to compare laparoscopic and medical conservative treatment for ectopic pregnancy. A total of 206 patients were treated for ectopic pregnancy at our hospital from January 2018 to June 2020. Among them, 46 underwent laparoscopic ipsilateral salpingectomy, 54 underwent laparoscopic ipsilateral salpingostomy with lesion removal, and 106 were treated conservatively with medication.
UNASSIGNED: The age range and average age of each group are provided, with no significant differences in these general demographic characteristics (p> 0.05). Both the salpingostomy and medication groups had higher rates of ectopic pregnancy compared to the salpingectomy group, with statistically significant differences (p< 0.05). The comparison of ectopic pregnancy rates between the salpingostomy and medication groups showed no significant difference. Within three years, the salpingostomy group had 10 cases of recurrent ectopic pregnancy, with 2 cases on the same side, while the medication group had 18 cases, with 8 cases on the same side. At 3 months after the normalization of blood β-HCG, the salpingostomy group showed 43 cases of tubal patency (patency rate: 79.63%), while the medication group showed 57 cases (patency rate: 53.77%), with a statistically significant difference between the two groups (p= 0.01).
UNASSIGNED: Laparoscopic surgery for ectopic pregnancy offers significant clinical benefits over conservative medical treatment, including higher rates of tubal patency and improved reproductive outcomes. These findings support laparoscopic surgery as an effective approach for the management of ectopic pregnancy.
UNASSIGNED: This study aims to investigate the clinical benefits of laparoscopic surgery in treating ectopic pregnancy, and its impact on tubal patency and reproductive outcomes.
UNASSIGNED: A clinical study was conducted to compare laparoscopic and medical conservative treatment for ectopic pregnancy. A total of 206 patients were treated for ectopic pregnancy at our hospital from January 2018 to June 2020. Among them, 46 underwent laparoscopic ipsilateral salpingectomy, 54 underwent laparoscopic ipsilateral salpingostomy with lesion removal, and 106 were treated conservatively with medication.
UNASSIGNED: The age range and average age of each group are provided, with no significant differences in these general demographic characteristics (p> 0.05). Both the salpingostomy and medication groups had higher rates of ectopic pregnancy compared to the salpingectomy group, with statistically significant differences (p< 0.05). The comparison of ectopic pregnancy rates between the salpingostomy and medication groups showed no significant difference. Within three years, the salpingostomy group had 10 cases of recurrent ectopic pregnancy, with 2 cases on the same side, while the medication group had 18 cases, with 8 cases on the same side. At 3 months after the normalization of blood β-HCG, the salpingostomy group showed 43 cases of tubal patency (patency rate: 79.63%), while the medication group showed 57 cases (patency rate: 53.77%), with a statistically significant difference between the two groups (p= 0.01).
UNASSIGNED: Laparoscopic surgery for ectopic pregnancy offers significant clinical benefits over conservative medical treatment, including higher rates of tubal patency and improved reproductive outcomes. These findings support laparoscopic surgery as an effective approach for the management of ectopic pregnancy.
摘要：
异位妊娠是全球孕产妇发病率和死亡率的主要原因。
■本研究旨在探讨腹腔镜手术治疗异位妊娠的临床益处，及其对输卵管通畅性和生殖结局的影响。
■进行了一项临床研究，以比较腹腔镜和内科保守治疗异位妊娠。2018年1月至2020年6月，共有206例异位妊娠患者在我院接受治疗。其中,46例接受腹腔镜同侧输卵管切除术，54例接受了腹腔镜同侧输卵管造口术并切除病变，106例接受药物保守治疗。
■提供了每个组的年龄范围和平均年龄，在这些一般人口统计学特征上没有显著差异(p>0.05)。与输卵管切除术组相比，输卵管造口术组和药物治疗组均有较高的异位妊娠率，差异具有统计学意义(p<0.05)。输卵管造口术组和药物组的异位妊娠率比较差异无统计学意义。三年之内,输卵管造口术组有10例复发性异位妊娠，同一侧有两个箱子，而药物组有18例，同一侧有8个病例。血β-HCG正常化后3个月,输卵管造口术组输卵管通畅43例(通畅率79.63%),药物治疗组57例(通畅率53.77%),两组之间的差异具有统计学意义（p=0.01）。
腹腔镜手术治疗异位妊娠比保守治疗具有显著的临床益处。包括更高的输卵管通畅率和改善的生殖结局。这些发现支持腹腔镜手术作为治疗异位妊娠的有效方法。
■本研究旨在探讨腹腔镜手术治疗异位妊娠的临床益处，及其对输卵管通畅性和生殖结局的影响。
■进行了一项临床研究，以比较腹腔镜和内科保守治疗异位妊娠。2018年1月至2020年6月，共有206例异位妊娠患者在我院接受治疗。其中,46例接受腹腔镜同侧输卵管切除术，54例接受了腹腔镜同侧输卵管造口术并切除病变，106例接受药物保守治疗。
■提供了每个组的年龄范围和平均年龄，在这些一般人口统计学特征上没有显著差异(p>0.05)。与输卵管切除术组相比，输卵管造口术组和药物治疗组均有较高的异位妊娠率，差异具有统计学意义(p<0.05)。输卵管造口术组和药物组的异位妊娠率比较差异无统计学意义。三年之内,输卵管造口术组有10例复发性异位妊娠，同一侧有两个箱子，而药物组有18例，同一侧有8个病例。血β-HCG正常化后3个月,输卵管造口术组输卵管通畅43例(通畅率79.63%),药物治疗组57例(通畅率53.77%),两组之间的差异具有统计学意义（p=0.01）。
腹腔镜手术治疗异位妊娠比保守治疗具有显著的临床益处。包括更高的输卵管通畅率和改善的生殖结局。这些发现支持腹腔镜手术作为治疗异位妊娠的有效方法。
